Antivirals for HCV improve kidney, cardiovascular diseases in diabetic patients
Wednesday, December 11, 2013 - 14:11
in Health & Medicine
Researchers reveal that antiviral therapy for hepatitis C virus (HCV) improves kidney and cardiovascular outcomes for patients with diabetes. Results show that incidences of kidney disease, stroke, and heart attack were lower in patients treated with pegylated interferon and ribavirin compared to HCV patients not treated with antivirals or diabetic patients not infected with the virus.